Current Drug Targets logo Bentham Science Publishers logo

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Related content
Volume 8, Number 2, February 2007

< previous issue | all issues | next issue >

Articles

Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders
pp. 205-216(12)
Authors: Reiter, Andreas; Walz, Christoph; P. Cross, Nicholas C.

Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
pp. 217-235(19)
Authors: Morgan, M. A.; Ganser, A.; M. Reuter, C. W.

Oncogenic Signaling in Acute Myeloid Leukemia
pp. 237-246(10)
Authors: Brandts, Christian H.; Berdel, Wolfgang E.; Serve, Hubert

The Mevalonate Pathway as a Therapeutic Target in the Ph-Negative Chronic Myeloproliferative Disorders
pp. 247-256(10)
Authors: Carl Hasselbalch, Hans; Riley, Caroline H.

Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
pp. 257-268(12)
Authors: Kessler, Torsten; Fehrmann, Frauke; Bieker, Ralf; Berdel, Wolfgang E.; Mesters, Rolf M.

Pathobiology of Osteoarthritis: Pathomechanisms and Potential Therapeutic Targets
pp. 271-282(12)
Authors: Roach, H. I.; Aigner, T.; Soder, S.; Haag, J.; Welkerling, H.

Cytokine Targeting in Osteoarthritis
pp. 283-292(10)
Authors: Blom, Arjen B.; van der Kraan, Peter M.; van den Berg, Wim B.

Molecular Targets in Osteoarthritis: Metalloproteinases and Their Inhibitors
pp. 293-303(11)
Authors: Burrage, P. S.; Brinckerhoff, C. E.

Role of Cathepsin K in Normal Joints and in the Development of Arthritis
pp. 315-323(9)
Authors: Salminen-Mankonen, H. J.; Morko, J.; Vuorio, E.

Osteoarthritis: Aging of Matrix and Cells - Going for a Remedy
pp. 325-331(7)
Authors: Aigner, T.; Haag, J.; Martin, J.; Buckwalter, J.

Cell Death and Apoptosis in Ostearthritic Cartilage
pp. 333-345(13)
Authors: Kim, H. A.; Blanco, F. J.

Antioxidant to Treat Osteoarthritis: Dream or Reality?
pp. 347-357(11)
Authors: Henrotin, Y.; Kurz, B.

Anabolic Factors in Degenerative Joint Disease
pp. 359-365(7)
Author: Sandell, L. J.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page